Revalesio Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-12-22
Last Posted Date
2011-10-04
Lead Sponsor
Revalesio Corporation
Target Recruit Count
12
Registration Number
NCT01264783
Locations
🇺🇸

Quintiles, Inc., Overland Park, Kansas, United States

Safety Study of Nebulized RNS60 to Treat Asthma.

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-01-27
Last Posted Date
2012-01-12
Lead Sponsor
Revalesio Corporation
Target Recruit Count
36
Registration Number
NCT01057498
Locations
🇺🇸

West Coast Clinical Trials, Cypress, California, United States

🇺🇸

Stanford University, Stanford, California, United States

Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers

First Posted Date
2009-01-15
Last Posted Date
2012-06-26
Lead Sponsor
Revalesio Corporation
Target Recruit Count
13
Registration Number
NCT00823446
Locations
🇺🇸

Roger Williams Medical Center, Providence, Rhode Island, United States

© Copyright 2024. All Rights Reserved by MedPath